Dexmethylphenidate Hydrochloride
Who holds supplier records for Dexmethylphenidate Hydrochloride? 7 organisations hold a current record for Dexmethylphenidate Hydrochloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: United States (3), India (1) and Germany (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Dexmethylphenidate Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/dexmethylphenidate-hydrochloride
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in United States
3 of the 5 current records with a recorded country list United States. Organisation country is not necessarily the manufacturing site.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dexmethylphenidate Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alkem Laboratories LimitedIndia Company GMP cert on recordActive DMF 32902 · latest filing Jun 2018
- Ampac Fine ChemicalsUnited StatesActive DMF 29784 · latest filing Oct 2015
- CURIA MISSOURI INCActive DMF 20385 · latest filing Mar 2007
- LONZA INCActive DMF 17117 · latest filing Jan 2004
- PURISYS LLCUnited StatesActive DMF 29411 · latest filing May 2016
- SIEGFRIED USA LLCGermanyActive DMF 13228 · latest filing Sept 1998
- SPECGX LLCUnited StatesActive DMF 30657 · latest filing Oct 2016
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Dexmethylphenidate Hydrochloride is the d-threo-enantiomer of the racemic methylphenidate hydrochloride, used as a central nervous system stimulant. It is primarily indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults.
Chemical identity
- IUPAC name
- methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate;hydrochloride
- Canonical SMILES
- COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2.Cl
- InChIKey
- JUMYIBMBTDDLNG-OJERSXHUSA-N
- Synonyms
- Focalin API, dex-methylphenidate hydrochloride, dexmethylphenidate hcl, focalin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Central Nervous System Stimulant
- Physiologic effect
- Central Nervous System Stimulation
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dexmethylphenidate Hydrochloride?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Dexmethylphenidate Hydrochloride: Alkem Laboratories Limited (India), Ampac Fine Chemicals (United States), CURIA MISSOURI INC, LONZA INC, PURISYS LLC (United States), SIEGFRIED USA LLC (Germany) and SPECGX LLC (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dexmethylphenidate Hydrochloride Drug Master Files are active?
Alkem Laboratories Limited (DMF 32902), Ampac Fine Chemicals (DMF 29784), CURIA MISSOURI INC (DMF 20385), LONZA INC (DMF 17117), PURISYS LLC (DMF 29411), SIEGFRIED USA LLC (DMF 13228) and SPECGX LLC (DMF 30657). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Dexmethylphenidate Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dexmethylphenidate Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.